<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Pharmacy News and Stories

DOPS Faculty

Faculty    Pharmacy    DOPS Faculty

Dr. Blake Hill Takes the Helm as Chair of the Pharmaceutical Sciences Department

The CU Skaggs School of Pharmacy and Pharmaceutical Sciences is thrilled to introduce Blake Hill, PhD, as Chair of the Department of Pharmaceutical Sciences (DOPS). Dr. Hill’s passion for making a difference in health, coupled with an eagerness to face the challenges posed by environmental and climate-induced changes, will propel the Department of Pharmaceutical Sciences to new heights at CU Pharmacy.

Author Brad Bobel | Publish Date March 25, 2024
Full Story

Press Coverage    DOPS Faculty

Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.

Author NewsMedical | Publish Date December 28, 2021
Full Story

Press Coverage    DOPS Faculty

How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.

Author Health.com | Publish Date December 28, 2021
Full Story

Press Coverage    DOPS Faculty

Covid pills are ‘very promising’ – but what are the challenges in using them?

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.

Author The Guardian | Publish Date December 28, 2021
Full Story

Press Coverage    DOPS Faculty

Robotic technology takes us into a new era of drug discovery

A cutting-edge robot that will cut screening time for new drugs in half to get more effective therapies to people and animals is busy doing lifesaving work. Professor Dan LaBarbera, PhD is the founding director of the Center for Drug Discovery at CU Anschutz.

Author Denver 7 | Publish Date October 19, 2021
Full Story

School of Pharmacy In the News

The Colorado Sun

For Some People, Their Genes and Their Cancer Drugs Don't Mix. A Colorado Center is Trying to Fix That

news outletThe Colorado Sun
Publish DateMarch 18, 2024

“Everybody always says, ‘This is so cool, it’s the future of medicine,’” said Dr. Christina Aquilante, the director of pharmacogenomics at the Center for Personalized Medicine. “It’s not the future. It’s the now. It’s happening.”

Full Story
NBC News

Study Links Cannabis Use to Heart Problems

news outletNBC News
Publish DateMarch 18, 2024

Dr. Robert Page, PharmD, appears on NBC Nightly News with Lester Holt to discuss cannabis use and heart problems.

Full Story

4 Common Pain Relievers and When to Use Them

news outletAARP
Publish DateFebruary 22, 2024

What’s the best over-the-counter pain medication? It depends on what hurts — and why. “If you can target the pain with a medication that treats the underlying cause, the pain relief will be better,” says Sunny Linnebur, PharmD.

Full Story

Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk

news outletMedscape
Publish DateFebruary 13, 2024

Adults using medical cannabis for chronic pain, especially those with cancer or cardiometabolic disease, have a slightly elevated risk of developing arrhythmia, according to an editorial by Robert Page, PharmD

Full Story